137 related articles for article (PubMed ID: 7461027)
1. Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis.
Lynn K; Braithwaite R; Dawling S; Rosser R
Eur J Clin Pharmacol; 1981 Jan; 19(1):73-7. PubMed ID: 7461027
[TBL] [Abstract][Full Text] [Related]
2. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
Oellerich M; Müller-Vahl H
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
[TBL] [Abstract][Full Text] [Related]
3. Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury.
Markowsky SJ; Skaar DJ; Christie JM; Eyer SD; Ehresman DJ
Ann Pharmacother; 1996 May; 30(5):443-8. PubMed ID: 8740320
[TBL] [Abstract][Full Text] [Related]
4. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
Odar-Cederlöf I; Borga O
Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
[TBL] [Abstract][Full Text] [Related]
5. Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients.
Ehrnebo M; Odar-Cederlöf I
Eur J Clin Pharmacol; 1975 Aug; 8(6):445-53. PubMed ID: 1233247
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.
Odar-Cederlöf I; Borgå O
Eur J Clin Pharmacol; 1974; 7(1):31-7. PubMed ID: 4852619
[No Abstract] [Full Text] [Related]
7. Alterations of phenytoin protein binding with in vivo haemodialysis in dialysis encephalopathy.
Steele WH; Lawrence JR; Elliott HL; Whiting B
Eur J Clin Pharmacol; 1979 Feb; 15(1):69-71. PubMed ID: 421730
[TBL] [Abstract][Full Text] [Related]
8. Distribution of antipyrine, phenylbutazone and phenytoin in experimental renal failure.
Van Peer AP; Belpaire FM; Rosseel MT; Bogaert MG
Pharmacology; 1981; 22(2):139-45. PubMed ID: 7208595
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of maprotiline intravenous kinetics and comparison of two oral doses.
Maguire KP; Norman TR; Burrows GD; Scoggins BA
Eur J Clin Pharmacol; 1980 Oct; 18(3):249-54. PubMed ID: 7439244
[TBL] [Abstract][Full Text] [Related]
10. Correlation and prediction of phenytoin protein binding using standard laboratory parameters in patients after renal transplantation.
Monaghan MS; Marx MA; Olsen KM; Turner PD; Bergman KL
Ther Drug Monit; 2001 Jun; 23(3):263-7. PubMed ID: 11360036
[TBL] [Abstract][Full Text] [Related]
11. The metabolic fate of [14C]oxaprotiline.HCl in man. I. Disposition and preliminary pharmacokinetics.
Dieterle W; Faigle JW; Imhof P; Sulc M; Wagner J
Xenobiotica; 1984 Apr; 14(4):303-10. PubMed ID: 6464500
[TBL] [Abstract][Full Text] [Related]
12. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
Odar-Cederlof I
Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
[TBL] [Abstract][Full Text] [Related]
13. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
Barth N; Alván G; Borgå O; Sjöqvist F
Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
[TBL] [Abstract][Full Text] [Related]
14. Plasma protein binding of phenytoin in 100 epileptic patients.
Peterson GM; McLean S; Aldous S; Von Witt RJ; Millingen KS
Br J Clin Pharmacol; 1982 Aug; 14(2):298-300. PubMed ID: 7104186
[TBL] [Abstract][Full Text] [Related]
15. Phenytoin binding in healthy volunteers.
Berg MJ; Ebert BE; Fincham RW; Schottelius DD
Ther Drug Monit; 1987 Dec; 9(4):384-8. PubMed ID: 3424404
[TBL] [Abstract][Full Text] [Related]
16. Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uremia treated with hemodialysis. Role of uremic compounds.
Dasgupta A; Abu-Alfa A
Am J Clin Pathol; 1992 Jul; 98(1):19-25. PubMed ID: 1615921
[TBL] [Abstract][Full Text] [Related]
17. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.
Reidenberg MM; Odar-Cederlöf I; von Bahr C; Borgå O; Sjöqvist F
N Engl J Med; 1971 Jul; 285(5):264-7. PubMed ID: 4378402
[No Abstract] [Full Text] [Related]
18. Bioavailability and kinetics of maprotiline.
Alkalay D; Wagner WE; Carlsen S; Khemani L; Volk J; Bartlett MF; LeSher A
Clin Pharmacol Ther; 1980 May; 27(5):697-703. PubMed ID: 7371367
[TBL] [Abstract][Full Text] [Related]
19. Heat inhibition of in vitro lipolysis and 14C ibuprofen protein binding in plasma from heparinized uraemic subjects.
Pearce GA; Brown KF
Life Sci; 1983 Oct; 33(15):1457-66. PubMed ID: 6621250
[TBL] [Abstract][Full Text] [Related]
20. Comparison of single-dose pharmacokinetics of imipramine and maprotiline in the elderly.
Hrdina PD; Rovei V; Henry JF; Hervy MP; Gomeni R; Forette F; Morselli PL
Psychopharmacology (Berl); 1980; 70(1):29-34. PubMed ID: 6775331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
